Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase
about
Chick embryo partial ischemia model: a new approach to study ischemia ex vivoRanolazine recruits muscle microvasculature and enhances insulin action in rats.Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.Ranolazine: a review of its use in chronic stable angina pectoris.Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.Intracellular Na+ overload causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes.Partial fatty acid oxidation inhibitors for stable angina.Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated heartsRanolazine: new approach for the treatment of stable angina pectoris.Ranolazine: a new approach to management of patients with angina.Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.Electrical plasticity and cardioprotection in myocardial ischemia--role of selective sodium channel blockers.Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental models.Effects of ranolazine on L-type calcium channel currents in guinea-pig single ventricular myocytes.Effects of ranolazine on fatty acid transformation in the isolated perfused rat liver.Anti-allergic activity of the Sophorae radix water extract in experimental animals.Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension.
P2860
Q28473867-191A3707-0567-4361-ADB5-CA40178DA816Q30456763-CDBE80D8-BCF5-4CF6-B5AF-1801D85C9D78Q34549619-7E192007-7762-4F34-9758-9F5091666A0CQ34566582-5F67B90A-AD34-47C0-9A33-756ADF977A92Q34573997-89595E55-E656-4A7B-9A06-7C86085F4B84Q34603278-E7E7213F-F22F-4968-B867-0C539D16EF60Q34628656-5AB274B7-8376-43CB-85AD-26C392048402Q35599994-A2D7653C-6108-4D0E-9B45-B7410BB7EF18Q36266000-22EDC5C2-781D-4761-B409-4DA1BB595E57Q36440871-03C07BF1-8BFE-474E-AA0E-447127D808FDQ36507053-D25A9D33-6CC4-4DDA-AA94-79FE2C72189DQ37599625-7ACBE3BB-AA5D-4543-93D8-4AF66F471A27Q38093148-6F0E609E-4CB0-432A-B9A1-98C733F98B4DQ38238926-64B34E6D-2A7A-4A6E-B9CE-F74B5BAEAC66Q42006866-9C6F7A4D-7991-4B4B-AAC1-F4AC59A4F0D0Q42948705-14F70531-5B5F-4178-9495-8DBFE6A0BC93Q43587765-97299A5D-1BE0-4886-9475-D47180591666Q49247394-E0273EBC-6D4B-4777-A26D-F64139109581Q53079510-5A4E46F4-13BD-488E-81A2-0162B76485C2
P2860
Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@ast
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@en
type
label
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@ast
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@en
prefLabel
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@ast
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@en
P2093
P2860
P1476
Protective effects of ranolazi ...... active pyruvate dehydrogenase
@en
P2093
J G McCormack
P2860
P304
P356
10.1111/J.1476-5381.1993.TB13637.X
P407
P577
1993-07-01T00:00:00Z